Request Batch
Amylin Receptor Agonist
Cagrilintide
5mg · Lyophilized
≥99% HPLC · Third-party verified · Lot-specific COA published
Strength
Amylin Receptor Agonist. ≥99% HPLC, third-party verified, lot-specific COA published before dispatch.
Request Batch
This strength is produced in limited lots and released to qualified researchers on request. Contact us to be notified when a verified, lot-tested batch is available.
RESEARCH USE ONLY. For in vitro and in vivo laboratory research use only. Not for human consumption, diagnostic, or therapeutic use. Sold exclusively to licensed researchers and institutions.
Batch / Lot
PYX-CAG05-001
CAS Number
2413562-64-4
Molecular Formula
C138H236N44O42S2
Molecular Weight
3210.7 g/mol
Presentation
5mg lyophilized powder
Storage & Handling
Lyophilized: -20C, 24 months. Reconstituted: 4C, use within 28 days.
COA
Lot-specific — published in the COA Library before dispatch
Cagrilintide is a long-acting amylin analogue designed to activate amylin (IAPP) receptors with structural modifications providing ~7-day half-life. Under active Phase 3 investigation (REDEFINE trials) in combination with semaglutide (CagriSema). High-relevance reference for amylin/GLP-1 convergent pathway research.
Lau DCW, et al. Amylin/GLP-1 receptor co-agonism study. Lancet. 2021.
